| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10232280 | Current Opinion in Biotechnology | 2011 | 7 Pages |
Abstract
⺠In vivo production results in effective and persistent levels of therapeutic protein ⺠Ex vivo modification of cells can be carried out in vitro under controlled conditions ⺠A cost-effective method would imply the use of stocks of gene-modified allogenic cells ⺠Encapsulation protects cells from the immune system.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
David Sánchez-MartÃn, Laura Sanz, Luis Álvarez-Vallina,